Duchenne muscular dystrophy (DMD) is a rare condition that is typically treated with the help of steroids, to manage symptoms, as scientists are yet...
Blackhawk Network (BHN) is working with Visa to move its network branded prepaid products distributed by third party retail networks from plastic to...
ARTICLE | FinancePlus: Roche’s Alecensa meets in ALK-positive NSCLC and updates from Carisma and FindCure By BioCentury Staff
September 1, 2023 11:16 PM UTC
China and Boston-based mRNA...
Roche has provided the first evidence that its oral anaplastic lymphoma kinase (ALK) inhibitor for non-small cell lung cancer (NSCLC) could be key in...
The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In...
Animal ethics approvalC57BL/6 mice were obtained from the Fudan University Animal Center.All animals were placed in stainless steel cages in a well-ventilated room maintained...
Dive Brief:
The number of biopharmaceutical jobs is growing despite the sector’s market turbulence, but the gains are concentrated to larger companies, according to a...
GSK on Thursday was cleared to broaden use of its cancer immunotherapy Jemperli, winning approval from the Food and Drug Administration to market the...
ARTICLE | Management TracksPlus: SVB bolsters its life science and healthcare sector with two new appointments, and updates from Concerto and Annexon By BioCentury...